Mihael H. Polymeropoulos
2019
In 2019, Mihael H. Polymeropoulos earned a total compensation of $4.3M as President and Chief Executive Officer at Vanda Pharmaceuticals, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $675,000 |
|---|---|
| Option Awards | $1,610,154 |
| Salary | $721,000 |
| Stock Awards | $1,237,200 |
| Other | $34,783 |
| Total | $4,278,137 |
Polymeropoulos received $1.6M in option awards, accounting for 38% of the total pay in 2019.
Polymeropoulos also received $675K in non-equity incentive plan, $721K in salary, $1.2M in stock awards and $34.8K in other compensation.
Rankings
In 2019, Mihael H. Polymeropoulos' compensation ranked 2,742nd out of 13,971 executives tracked by ExecPay. In other words, Polymeropoulos earned more than 80.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,742 out of 13,971 | 80th |
Division Manufacturing | 988 out of 5,698 | 83rd |
Major group Chemicals And Allied Products | 326 out of 2,197 | 85th |
Industry group Drugs | 265 out of 1,883 | 86th |
Industry Pharmaceutical Preparations | 195 out of 1,395 | 86th |
Source: SEC filing on April 22, 2020.
Polymeropoulos' colleagues
We found four more compensation records of executives who worked with Mihael H. Polymeropoulos at Vanda Pharmaceuticals in 2019.
2019
Gian Reverberi
Vanda Pharmaceuticals
Former Senior Vice President, Chief Commercial Officer
2019
James Kelly
Vanda Pharmaceuticals
Chief Financial Officer
2019
Timothy Williams
Vanda Pharmaceuticals
General Counsel
2019
Gunther Birznieks
Vanda Pharmaceuticals